Literature DB >> 11135307

Revelations of the RYK receptor.

M M Halford1, S A Stacker.   

Abstract

Significant progress has been made over the last decade in elucidating the mechanisms employed by receptor protein tyrosine kinases (RTKs) in transducing extracellular signals critical for the regulation of diverse cellular activities. Nevertheless, revealing the biological significance of a subset of the RTKs that contain catalytically inactive protein tyrosine kinase domains has proven more elusive. ErbB3 has served as the prototype for models of catalytically inactive RTK function, performing the role of signal diversification in heterodimeric receptor complexes with other ErbB subfamily members. The receptor related to tyrosine kinases (RYK) is unique amongst the catalytically inactive RTKs. Based on structural or functional properties of the extracellular domain, RYK cannot be classified into an existing RTK subfamily. Recent genetic analyses of mouse Ryk and its Drosophila orthologue derailed have defined a role for this novel subfamily of receptors in the control of craniofacial development and neuronal pathway selection, respectively. Recent biochemical data lead us to propose a model that involves RYK in signal crosstalk and scaffold assembly with Eph receptors. This model is consistent with the established roles of Eph receptors and ephrins in craniofacial and nervous system morphogenesis. BioEssays 23:34-45, 2001. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135307     DOI: 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.0.CO;2-D

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  13 in total

1.  The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling.

Authors:  Maria L Macheda; Willy W Sun; Kumudhini Kugathasan; Benjamin M Hogan; Neil I Bower; Michael M Halford; You Fang Zhang; Bonnie E Jacques; Graham J Lieschke; Alain Dabdoub; Steven A Stacker
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Src kinase modulates the activation, transport and signalling dynamics of fibroblast growth factor receptors.

Authors:  Emma Sandilands; Shiva Akbarzadeh; Anna Vecchione; David G McEwan; Margaret C Frame; John K Heath
Journal:  EMBO Rep       Date:  2007-11-02       Impact factor: 8.807

Review 3.  Eph/ephrin signaling: networks.

Authors:  Dina Arvanitis; Alice Davy
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

4.  Cdc37 regulates Ryk signaling by stabilizing the cleaved Ryk intracellular domain.

Authors:  Jungmook Lyu; Robin L Wesselschmidt; Wange Lu
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

5.  Expression of Trk A and Src and their interaction with ERβ ligand binding domain show age and sex dependent alteration in mouse brain.

Authors:  M K Thakur; V Paramanik
Journal:  Neurochem Res       Date:  2011-10-20       Impact factor: 3.996

Review 6.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

Review 7.  Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  FEBS J       Date:  2015-07-04       Impact factor: 5.542

Review 8.  The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer.

Authors:  Jennifer L Hsu; Mien-Chie Hung
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

9.  Wnt5b-Ryk pathway provides directional signals to regulate gastrulation movement.

Authors:  Shengda Lin; Lisa M Baye; Trudi A Westfall; Diane C Slusarski
Journal:  J Cell Biol       Date:  2010-07-26       Impact factor: 10.539

10.  Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.

Authors:  Jason D Berndt; Atsushi Aoyagi; Peitzu Yang; Jamie N Anastas; Lan Tang; Randall T Moon
Journal:  J Cell Biol       Date:  2011-08-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.